Distal revascularization-interval ligation for ischemic steal syndrome after hemodialysis access. Experience in 23 patients Background: The creation of vascular accesses for hemodialysis can cause distal ischemia and steal syndromes. Aim: To assess the effectiveness of the technique of distal revascularization-interval ligation to alleviate distal ischemia and preserve vascular access. Material and Methods: Retrospective review of medical records, identifying 23 patients (13 women, aged between 24 and 79 years), with distal ischemia secondary to a vascular access for hemodialysis, that were treated with distal revascularization-interval ligation. Patient characteristics and outcome of the surgical procedure were recorded. Results: Fourteen patients were diabetic and 15 had high blood pressure. All had the vascular access in the elbow, 20 were done with vein and three were prosthetic. Steal appeared in a lapse ranging from hours to six years after performing the procedure. In 14 patients it appeared before 12 months. Revascularization was performed between 1 day and three months after the appearance of the steal syndrome. Seventeen patients (74%) had a substantial relief of ischemic symptoms, with healing of ulcers and digital amputations. Three patients died soon after the procedure (13%). In two the pain persisted, requiring a banding of the access, that fi nally became thrombosed. One patient required a distal forearm amputation. Thirteen patients (56%) had a late death after the procedure. After revascularization, the vascular accesses were used for a mean of two years. Conclusions: Revascularizationinterval ligation relieves distal ischemia and maintains the patency of the vascular access for hemodialysis. Patients with steal syndrome secondary to vascular access are of high risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.